Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
245.68B
Market cap245.68B
Price-Earnings ratio
14.93
Price-Earnings ratio14.93
Dividend yield
2.18%
Dividend yield2.18%
Average volume
21.37M
Average volume21.37M
High today
$55.85
High today$55.85
Low today
$54.08
Low today$54.08
Open price
$54.80
Open price$54.80
Volume
10.44M
Volume10.44M
52 Week high
$139.74
52 Week high$139.74
52 Week low
$45.05
52 Week low$45.05

NVO News

Sherwood News 4h
Ro’s CEO on how GLP-1s built the framework for “pharm-to-table”

Normally, if your insurer doesn’t cover a medication, you would buy it directly from your pharmacy, which bought it from a wholesaler, which bought it from the...

Ro’s CEO on how GLP-1s built the framework for “pharm-to-table”
Simply Wall St 9h
Why Hims & Hers Health Is Down 10.2% After Novo Nordisk Ends Weight-Loss Drug Partnership

In August 2025, Novo Nordisk ended its partnership with Hims & Hers Health over the promotion and sale of compounded GLP-1 weight-loss drugs and instead announc...

Why Hims & Hers Health Is Down 10.2% After Novo Nordisk Ends Weight-Loss Drug Partnership
TipRanks 1d
Novo Nordisk’s New Weight Control Drug Completes Phase 1 Study

Novo Nordisk ((DE:NOVA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

Analyst ratings

52%

of 33 ratings
Buy
51.5%
Hold
45.5%
Sell
3%

More NVO News

Benzinga 1d
Novo Nordisk Freezes Hiring As Wegovy Faces Copycats

Novo Nordisk A/S NVO has reportedly imposed a global hiring freeze for nonessential roles, as the drugmaker faces rising competition from copycat versions of We...

Novo Nordisk Freezes Hiring As Wegovy Faces Copycats
TipRanks 1d
Novo Nordisk freezes non-critical hiring, Reuters reports

Novo Nordisk (NVO) has implemented a global hiring freeze covering job roles that are not critical for its business, the company confirmed to Reuters. “We curre...

Seeking Alpha 1d
Novo Nordisk’s new CEO is said to start hiring freeze to cut costs

Novo Nordisk (NVO) reportedly implemented a global hiring freeze as the Danish drugmaker seeks to cut costs and regain its footing in the competitive market for...

Novo Nordisk’s new CEO is said to start hiring freeze to cut costs
Reuters 1d
Drugmaker Novo Nordisk enacts worldwide hiring freeze for non-critical job roles - Reuters

...

Drugmaker Novo Nordisk enacts worldwide hiring freeze for non-critical job roles - Reuters
Benzinga 2d
New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data

Eli Lilly and Co. LLY and Novo Nordisk A/S NVO are expected to launch new obesity-treatment pills in the U.S. next year at prices comparable to their existing i...

New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data
Benzinga 2d
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada on Tuesday approved Novo Nordisk's NVO Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2...

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
Benzinga 2d
GoodRx Stock Is Sliding Tuesday: What's Going On?

Zinger Key Points GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partnership with Novo...

GoodRx Stock Is Sliding Tuesday: What's Going On?
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.